Comparison of outcomes after hospitalization for worsening heart failure, myocardial infarction, and stroke in patients with heart failure and reduced and preserved ejection fraction

被引:36
|
作者
Kristensen, Soren L. [1 ,2 ]
Jhund, Pardeep S. [1 ]
Kober, Lars [3 ]
Preiss, David [1 ]
Kjekshus, John [4 ]
McKelvie, Robert S. [5 ]
Zile, Michael R. [6 ,7 ]
Anand, Inder S. [8 ,9 ]
Wikstrand, John [10 ]
Wedel, Hans [11 ]
Komajda, Michel [12 ,13 ]
Carson, Peter E. [14 ,15 ]
Cleland, John G. F. [16 ,17 ]
McMurray, John J. V. [1 ]
机构
[1] Univ Glasgow, BHF Cardiovasc Res Ctr, Glasgow G12 8TA, Lanark, Scotland
[2] Gentofte Univ Hosp, Dept Cardiol, Copenhagen, Denmark
[3] Univ Copenhagen, Rigshosp, Dept Cardiol, DK-2100 Copenhagen, Denmark
[4] Univ Oslo, Rikshosp, Dept Cardiol, N-0027 Oslo, Norway
[5] McMaster Univ, Hamilton Hlth Sci, Hamilton, ON, Canada
[6] Ralph H Johnson Dept Vet Affairs Med Ctr, Charleston, SC USA
[7] Med Univ S Carolina, Charleston, SC 29425 USA
[8] Vet Affairs Med Ctr, Minneapolis, MN USA
[9] Univ Minnesota, Minneapolis, MN USA
[10] Gothenburg Univ, Wallenberg Lab Cardiovasc Res, Sahlgrenska Acad, Gothenburg, Sweden
[11] Nord Sch Publ Hlth, Gothenburg, Sweden
[12] Univ Paris 06, Hosp Pitie Salpetriere, Paris, France
[13] Inst ICAN, Paris, France
[14] Georgetown Univ, Washington, DC USA
[15] Washington DC Vet Affairs Med Ctr, Washington, DC USA
[16] Univ London Imperial Coll Sci Technol & Med, Royal Brompton Hosp, Natl Heart & Lung Inst, London, England
[17] Univ London Imperial Coll Sci Technol & Med, Harefield Hosp, Natl Heart & Lung Inst, London, England
关键词
Heart failure; Clinical trials; HF-PEF; HF-REF; Mortality; ROSUVASTATIN; TRIAL; PROGRESSION; IRBESARTAN; DESIGN; CORONA;
D O I
10.1002/ejhf.211
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
AimsTo investigate the prognostic significance of hospitalization for worsening heart failure (WHF), myocardial infarction (MI), and stroke in patients with chronic heart failure (HF). Methods and resultsWe studied 5011 patients with HF and reduced EF (HF-REF) in the CORONA trial and 4128 patients with HF and preserved EF (HF-PEF) in the I-Preserve trial. Adjusted hazard ratios (HRs) for death were estimated for 0-30 days and 31 days after first post-randomization WHF, MI, or stroke used as a time-dependent variable, compared with patients with none of these events. In CORONA, 1616 patients (32%) had post-randomization first events (1223 WHF, 216 MI, 177 stroke), and the adjusted HR for mortality 30 days after an event was: WHF 7.21 [95% confidence interval (CI) 2.05-25.40], MI 23.08 (95% CI 6.44-82.71), and stroke 32.15 (95% CI 8.93-115.83). The HR for mortality at >30 days was: WHF 3.62 (95% CI 3.11-4.21), MI 4.41 (95% CI 3.23-6.02), and stroke 3.19 (95% CI 2.21-4.61). In I-Preserve, 896 patients (22%) experienced a post-randomization event (638 WHF, 111 MI, 147 stroke). The HR for mortality 30 days was WHF 31.77 (95% CI 7.60-132.81), MI 154.77 (95% CI 34.21-700.17), and stroke 223.30 (95% CI 51.42-969.78); for >30 days it was WHF 3.36 (95% CI 2.79-4.05), MI 3.29 (95% CI 2.14-5.06), and stroke 5.13 (95% CI 3.61-7.29). ConclusionsIn patients with both HF-REF and HF-PEF, hospitalization for WHF was associated with high early and late mortality. The early relative risk of death was not as great as following MI or stroke, but the longer term relative risk of death was similar following all three types of event. Numerically, more deaths occurred following WHF because it was a much more common event.
引用
收藏
页码:169 / 176
页数:8
相关论文
共 50 条
  • [31] Frailty and Post-hospitalization Outcomes in Patients With Heart Failure With Preserved Ejection Fraction
    Goyal, Parag
    Yum, Brian
    Navid, Pedram
    Chen, Ligong
    Kim, Dae H.
    Roh, Jason
    Jaeger, Byron C.
    Levitan, Emily B.
    AMERICAN JOURNAL OF CARDIOLOGY, 2021, 148 : 84 - 93
  • [32] DIFFUSE MYOCARDIAL FIBROSIS IS GREATLY ELEVATED IN MALES WITH HEART FAILURE WITH REDUCED EJECTION FRACTION, BUT NOT HEART FAILURE WITH PRESERVED EJECTION FRACTION
    Desai, Sanjal
    Haines, Philip
    Zamani, Payman
    Konda, Prasad
    Shiva-Kumar, Prithvi
    Peddireddy, Shivapriya
    Shekhar, Rahul Chandra
    Jain, Snigdha
    Kers, Scott
    Ferrari, Victor
    Chirinos, Julio
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (12) : A967 - A967
  • [33] Features of very elderly heart failure patients between heart failure with preserved ejection fraction and heart failure with reduced ejection fraction.
    Satogami, K. Keisuke
    Nozawa, Y.
    Akasaka, T.
    EUROPEAN JOURNAL OF HEART FAILURE, 2016, 18 : 421 - 421
  • [34] Sacubitril/valsartan in patients with mildly reduced or preserved ejection fraction and worsening heart failure: A review
    Zhirov, Igor V.
    Safronova, Natalia V.
    Tereshchenko, Sergey N.
    TERAPEVTICHESKII ARKHIV, 2023, 95 (09) : 802 - 809
  • [35] CLINICAL PHENOTYPE OF PATIENTS WITH HEART FAILURE WITH STABLE MID-RANGE EJECTION FRACTION IN COMPARISON TO PATIENTS WITH HEART FAILURE WITH STABLE REDUCED EJECTION FRACTION AND HEART FAILURE WITH STABLE PRESERVED EJECTION FRACTION
    Soufi, Mohamad Khaled
    Jain, Rishabh R.
    McFarland, Joseph R.
    Pinsky, Simon
    Rana, Milin N.
    Dang, Alexander
    Khalife, Wissam
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 77 (18) : 613 - 613
  • [36] Ultrafiltration in Heart Failure With Preserved Ejection Fraction Comparison With Systolic Heart Failure Patients
    Jefferies, John L.
    Bartone, Cheryl
    Menon, Santosh
    Egnaczyk, Gregory F.
    O'Brien, Thomas M.
    Chung, Eugene S.
    CIRCULATION-HEART FAILURE, 2013, 6 (04) : 733 - 739
  • [37] QTc INTERVAL IN PATIENTS WITH HEART FAILURE WITH REDUCED EJECTION FRACTION VS. HEART FAILURE WITH PRESERVED EJECTION FRACTION
    John, L. A.
    Christian, E. A.
    Harper, Y. I.
    Flatt, D. M.
    Heckle, M. R.
    Heard, B. Z.
    Jasper, J. B.
    Ramos, B. M.
    Weber, K. T.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2017, 65 (02) : 429 - 430
  • [38] Secondary valve regurgitation in patients with heart failure with preserved ejection fraction, heart failure with mid-range ejection fraction, and heart failure with reduced ejection fraction
    Bartko, Philipp E.
    Hulsmann, Martin
    Hung, Judy
    Pavo, Noemi
    Levine, Robert A.
    Pibarot, Philippe
    Vahanian, Alec
    Stone, Gregg W.
    Goliasch, Georg
    EUROPEAN HEART JOURNAL, 2020, 41 (29) : 2799 - +
  • [39] Heart failure with preserved ejection fraction: A precursor of heart failure with reduced ejection fraction or a distinct syndrome?
    Miani, Daniela
    Badano, Luigi P.
    De Biaggio, Paola
    Albanese, Maria Cecilia
    Ghidina, Marco
    Proclemer, Alessandro
    Fioretti, Paolo
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2011, 149 (01) : 139 - 140
  • [40] Quality of Life Is Equally Impaired in Reduced and Preserved Ejection Fraction Heart Failure after Hospitalization
    Anderson, Tyler
    Dangl, Michael
    Anderson, Shawn D.
    Malloy, Samantha
    Jungklaus, Tamarah
    Cleeton, Tim
    Perez, Jose
    Chapman, Don
    Schmalfuss, Carsten
    Schofield, Richard S.
    JOURNAL OF CARDIAC FAILURE, 2013, 19 (08) : S41 - S42